Company History

             
 
2000A. D.
  • BioWare Technologies Co., Ltd. was approved by Ministry of Economic Affairs to be established on 12th August. At the time of establishment, the share capital was 60 million ntd.
2001A. D.
  • Mosquito Bioattractant got National Biotechnology & Medical Quality Award in 2001.
2002A. D.
  • Got the business license of wholesale and retail industry of tobacco and alcohol in April.
  • Cooperated with AMAZON BIOTECHNOLOGY CO., established a producing line of fruit wine fermentation, and assisted the Company to gain the tobacco and alcohol manufacturing license from Ministry of Finance in June.
  • Obtained the registration certificate for the microbial chemical products manufacturing factory issued by the Ministry of Economic Affairs in June. The certificate no. is 99-606602-00.
  • Hoped to increase capital for 20 million ntd, and received really 80 million ntd of share capital in June.
  • Signed a public stock offering and public listing contract with GRANT THORNTON in July.
  • Signed a contract for the public stock offering and public listing with MEGA HOLDING in August.
  • The brand "TIPSY” weak liquor started to be sold in FAMILY MART in August.
  • Accomplished the prototype of gene gun in September.
  • Gene gun got「1st Biotechnology and Medical Care Innovation Award」in October.
  • "Tipsy” weak liquor got「National Biotechnology and Medical Quality Award」in October 2002.
  • BioWare mosquito attractant got the “manufacturing license of environmental and microbial agent” from Environmental Protection Agency.
2003A. D.
  • Hoped to increase capital for 17 million, acturally receiving 97 million ntd of share capital in July.ital in July.
  • Joined the Biotechnica 2003 in Hannover, Germany with the technique of "Low Pressure Gas Accelerated Gene Gun" in October.
  • Signed with National Taiwan University Hospital a cooperating contract for "co-developing a new type of gene gun for the treatment of cervical cancer" in December.
2004A. D.
  • Hoped to increase capital for 6 million, acturally receiving 103 million ntd of share capital in January.
  • With the project “development and application of biological trapping bait”, BioWare Technologies Co., Ltd. applied research and development grants of “Small Business Innovation Research” from the Technical Department of the Ministry of Economic Affairs. The schedule was from January 1, 2004 to December 31, 2004.
  • BioWare Technologies Co., Ltd. and Academia Sinica signed a "biomaterial transfer contract" in May.
  • With the project “Technical feasibility analysis of a new low-pressure gene gun applied for genetic vaccine”, BioWare Technologies Co., Ltd. applied research and development grants of “Small Business Innovation Research” from the Technical Department of the Ministry of Economic Affairs. The schedule was from June 1, 2004 to November 30, 2004.
2005A. D.
  • "Low pressure-accelerated particle gene gun " obtained R.O.C. patent (No I 226905) in February.
  • BioWare signed with National Cheng Kung University about the cooperative contract of the project "The technical feasibility analysis of novel gene gun applying to endogenous gene vaccine" in July.
2006A. D.
  • “MICROBE-MEDIATED METHOD AND APPARATUS FOR ATTRACTING MOSQUITOES”(2) obtained R.O.C. patent (No I 247579) in January.
  • “MICROBE-MEDIATED METHOD AND APPARATUS FOR ATTRACTING MOSQUITOES” obtained R.O.C. patent (No I 246885) in January.
  • With the project “Development and application of naked DNA delivery with low pressure gas accelerated gene gun”, BioWare applied research and development grants of “Small Business Innovation Research” from the Technical Department of the Ministry of Economic Affairs in August. The schedule was from June 1, 2004 to November 30, 2004.
  • BioWare Signed with "National Taiwan University" for the commissioned research contract of the project "Research and Application of naked DNA delivery with low pressure gas accelerated gene gun ".
  • BioWare applied to IBMI (Institute of Biotechnology and Medicine Industry) for the SNQ (Symbol of National Quality) of Biotechnology in 2006 with “High Efficiency Bio-attractant bait for trapping Mosquitoes” in December
2007A. D.
  • Hoped to increase capital for 12.87 million, really received 115.87 million ntd of share capital in August.
  • “Low Pressure Gas Accelerated Gene Gun “ of the Company obtained R.O.C. patent (No. I 290057) in November.
  • The “Microbe - Mediated Method and Apparatus for Attracting Mosquito” of the Company obtained Japanese patent (No.3902947) in November
2008A. D.
  • BioWare signed with Wealtec Bioscience Co., Ltd. about the global sale contract of “Low Pressure Air Accelerated Gene Gun for Lab” in November
2009A. D.
  • BioWare has obtained R. O. C. patent of “A rapid detecting method for Acinetobacter baumannii” (No. I 306508) in January
  • “Microbe - Mediated Method and Apparatus for Attracting Mosquito” of BioWare was granted with Europe patent in March
  • “Low Pressure Gas Accelerated Gene Gun” of BioWare gained US patent in September.
  • The company signed a contract for the sale of biological mosquito traps and baits with DONG JIN TRADING CO., LTD in September
2010A. D.
  • Hoped to increase capital for 24.12 million, received really 140 million ntd of share capital in February.
  • “METHOD OF MANUFACTURING LOW ALCOHOL SPARKLING FRUIT WINE” obtained R.O.C. patent (No. I 324179) in May
  • BioWare has been granted Europe (Germany, Britain, France, Italy, Sweden, Netherlands, Switzerland, Ireland, Portugal) patent of “Low Pressure Gene Accelerated Gene Gun” (No. 1444999) in July
2011A. D.
  • Hoped to increase capital for 24.12 million, received really 140 million ntd of share capital in February.
  • The company signed a "strategic alliance" cooperating agreement with FOSHAN JINKUIZI SCIENCE AND TECHNOLOGY CO., LTD., a key high-tech enterprise in China Torch Program. The two parties formally cooperated in research, development, product manufacturing, and market channel and marketing, in March.
  • Dr. Marie-Pierre de Béthune, the Vice President of JOHNSON & JOHNSON COMPANY in US, visited BioWare Technologies Co., Ltd. After listening the company's speech about research and developing products - the needle-free drug delivery device project, the Vice President signed a memorandum of cooperation with BioWare in April.
  • “Low Pressure Gas Accelerated Gene Gun” of the Company obtained Japan patent (No. 4790981) in July.
  • BioWare has been granted R.O.C patent of ”Low Pressure Gas Accelerated Gene Delivery Device and the Delivery Tube Structure” (No. I 349708) in October.
2013A. D.
  • As BioWare started to build Yilan Factory, the Yilan County Magistrate Lin arrived and hosted the Ground Breaking Ceremony.
2014A. D.
  • Yilan Factory building was accomplished in May.
2016A. D.
  • Aesthetic medicine device Bio-Jet molecular Nebulizer gained certificate of ISO 9001:2015 in October.
  • Aesthetic medicine device Bio-Jet molecular Nebulizer gained certificate of ISO 14001:2015 in October.
  • Aesthetic medicine device Bio-Jet molecular Nebulizer gained certificate of ISO 18001:2015 in October.
  • The GMP cleanroom of BioWare Technologies Co., Ltd. Yilan Factory was accomplished in December.
2017A. D.
  • BioWare got Pharmacist manufacturing license of BioWare Technologies Co., Ltd. Yilan Factory in January
  • Medical and beauty device Bio-Jet molecular Nebulizer gained certificate of ISO 13485:2012 in January.
  • Medical and beauty device Bio-Jet molecular Nebulizer passed the review of FDA in November.
2018A. D.
  • Aesthetic medicine device Bio-Jet molecular Nebulizer gained certificate of ISO 9001:2015 in October.  
  • Aesthetic medicine device Bio-Jet molecular Nebulizer gained certificate of ISO 14001:2015 in October.
  • Aesthetic medicine device Bio-Jet molecular Nebulizer gained certificate of ISO 13485:2016 in October.